Skip to content Skip to footer

CRASH-3

Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomized, placebo-controlled trial

Completed

Published inThe LancetYearApril, 2025DepartmentClinical ResearchShare